ClinicalTrials.gov
ClinicalTrials.gov Menu

rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01525836
Recruitment Status : Completed
First Posted : February 3, 2012
Last Update Posted : April 20, 2016
Sponsor:
Collaborators:
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
The First Affiliated Hospital of Anhui Medical University
The First Affiliated Hospital of Dalian Medical University
Shandong Provincial Hospital
Shenzhen Second People's Hospital
First Hospital of China Medical University
Information provided by (Responsible Party):
Ming Hou, Shandong University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : June 2014
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):